• / Free eNewsletters & Magazine
  • / My Account
Home>Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

3party Content

Sat, 30 Aug 2014

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.